Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sense of oppression; weakness; Death NOS; Hypertension arterial; Hypertension arterial; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-MA20211046. A 77-year-old female patient received BNT162B2 (COMIRNATY; lot number: ET3620), via intramuscular route of administration on 18Mar2021 (at the age of 77 years) at a single dose for COVID-19 immunization. Medical history included COVID-19, diabetes, and arterial hypertension. The patient''s concomitant medications were not reported. The patient experienced hypertension arterial on 21Mar2021; sense of oppression and weakness on 22Mar2021; and death NOS on 22Mar2021. The patient underwent lab test which included correct oxygen saturation on an unspecified date. The patient died on 22Mar2021 due to the events. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: weakness; Death NOS; Hypertension arterial; Hypertension arterial; Sense of oppression
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166